Rebranding PCOS to Reflect a Whole-Body Metabolic Disorder

Health experts in Jersey have welcomed the renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), arguing that the new title better captures the reality of a condition that impacts over 170 million women worldwide. The International PCOS Network, which implemented the change on 12 May, stated that the update aims to enhance public understanding, thereby facilitating more accurate diagnoses and effective treatments.

Jessica Pinel, a nutritionist and chair of PCOS Jersey, emphasized that the previous terminology was restrictive. Diagnosed three years ago after spending more than £3,000 on treatment, Pinel noted that the term "PCOS" misleadingly suggested the disorder was confined to the ovaries. In reality, it is a systemic issue affecting the entire body.

"The term PCOS limited the condition to having an effect on women's ovaries, whereas we know that it is a full-body condition," Pinel explained. She highlighted the diverse and debilitating nature of the symptoms, which include irregular menstruation, weight gain, elevated male hormones, fatigue, unwanted hair growth, acne, brain fog, and infertility.

Pinel stressed that the name change could help women access appropriate support for this wide spectrum of issues. However, she warned against relying on social media for medical information, citing the prevalence of misinformation on platforms like TikTok, Instagram, and Facebook. She pointed to a 2024 BBC investigation that revealed influencers were peddling fake cures for the condition. Instead, Pinel urged individuals to seek professional guidance and emphasized the right to a second opinion.

"I wasn't diagnosed the first few times. I had those exploratory tests, so I sought out a secondary opinion because I know my body," she said. "If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Jersey GP Dr. Jessica Langtree-Marsh echoed these sentiments, describing PCOS/PMOS as "hugely under-researched and hugely misunderstood." She criticized the medical community for often overlooking the condition until a patient seeks fertility treatment, describing this approach as inadequate.

"We see it as just simply: 'Come back when you want to have a baby and we'll fix it then,' but actually, we need to look at this as a lifespan condition," Langtree-Marsh said. She advocated for a shift in treatment strategies, moving beyond a sole reliance on contraceptive pills toward metabolic medications that address the broader physiological impacts of the syndrome.

The original condition was identified 70 years ago by surgeons Dr. Irving Stein and Dr. Michael Leventhal, who named it Stein-Leventhal Syndrome after observing specific ovarian characteristics in women with amenorrhea. Langtree-Marsh noted that the subsequent name, PCOS, incorrectly implied an ovarian-centric issue.

"So the rebranded PMOS is trying to appreciate that it affects women more generally rather than just the ovaries, so that it's a whole body condition," she said. While acknowledging that the new name is a mouthful, Langtree-Marsh welcomed the shift in definition. She also noted that a women’s health strategy, mandated by the Government Plan, is scheduled for publication later this year.

Source: BBC News Generated at: 2026-05-26 05:27:03 UTC